The federal financing of large-scale engineering projects
Abstract The financial condition of the federal government can not be a source of comfort to the managers of large-scale projects. On the one hand, a gradual absorption of the large deficits into a growing economy increases the financial risks of large projects. On the other hand, the significant cuts in federal spending are likely to fall disproportionately on these same projects. As a result strategic thinking about such ventures will need to include: a) financial mechanisms that place greater reliance on private resources, states and localities and, with that reliance, allow greater non-federal participation in project design and management; b) the way that the financial structure of a large-scale project can build and nurture the coalition of interests essential for its survival; c) the concept that a large scale project is a provider of services, rather than an object of intrinsic value; and d) meshing the financial and technological characteristics of a macro-engineering project with these new realities.
Cool Water: Demonstration of a Clean and Efficient New Coal Technology
Cool Water, the world's first commercial-scale, integrated coal gasification combined cycle power plant, has been operating successfully since May 1984 near Barstow, California. The 100-megawatt plant, which was completed ahead of schedule and under budget, is probably the cleanest coal-fired power generating facility now in commercial operation. An ongoing demonstration program at Cool Water shows that future baseload power plants that use this technology can be built modularly in increments of a few hundred megawatts and compete economically with much larger, conventional coal-fired power plants equipped for flue gas desulfurization.
Atomistic insight into novel co-delivery of doxorubicin and paclitaxel using fullerene modified by dimethyl acrylamide trimethyl chitosan: A computational study

 Background: The distribution of drugs could not be controlled in the conventional drug delivery system. This has led to the development of a smart nanoparticle-based drug delivery system, known as smart drug delivery systems. In cancer research, novel biocompatible nanocarriers have received much attention for various ranges of anticancer drugs.In the current study, the effect of a novel co-polymer "dimethyl acrylamide-trimethyl chitosan" was investigated on drug delivery of doxorubicin and paclitaxel utilizing modified fullerene nanocarrier. This study was performed via molecular dynamics simulation based on acidic pH sensitivity of the cancer microenvironment. Furthermore, hydrogen bonds, diffusion coefficient, gyration radius, and drug-carrier interaction energies were investigated here. Interestingly, a simultaneous pH and temperature-sensitive system was proposed for paclitaxel and doxorubicin for a co-polymer. A pH-sensitive and temperature-sensitive copolymer was used based on trimethyl chitosan and dimethyl acrylamide, respectively. In such a dualistic approach, co-polymer makes an excellent option to have two properties in one bio-polymer. Results: The results suggest the dramatic and indisputable role of the co-polymer in the release of doxorubicin and paclitaxel in cancerous tissues, as well as an increased biocompatibility and drug uptake in a neutral state. The validation test was performed by repeated simulations of a similar article. The results are very close to those of the reference paper .Conclusions: Overall, conjugated fullerene and dimethyl acrylamide-trimethyl chitosan (DMAA-TMC) as carriers can be a good proposition for loading, delivery, and release of anti-cancer drugs based on a pH/temperature-sensitive smart drug delivery system.